The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Blinatumomab: A historical perspective
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516
Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Intratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397
Kalos, M., Levine, B. L., Porter, D. L., Katz, S., Grupp, S. A., Bagg, A., & June, C. H. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002842 · Cited by 2,388
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Swann, J. B., & Smyth, M. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31405 · Cited by 1,447
Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody
Bargou, R., Leo, E., Zugmaier, G., Klinger, M., Goebeler, M., Knop, S., Noppeney, R., Viardot, A., Hess, G., Schuler, M., et al. (2008) · Science · doi:10.1126/science.1158545 · Cited by 1,078
Self-citationTopp, M. S., Kufer, P., Gökbuget, N., Goebeler, M., Klinger, M., Neumann, S., Horst, H.-A., Raff, T., Viardot, A., Schmid, M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.7270 · Cited by 913
Self-citationImpairment of T-cell-dependent B-cell responses and B-l cell development in CD19-deficient mice
Rickert, R. C., Rajewsky, K., & Roes, J. (1995) · Nature · doi:10.1038/376352a0 · Cited by 664
Bispecific T-Cell Engaging Antibodies for Cancer Therapy
Baeuerle, P. A., & Reinhardt, C. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0547 · Cited by 592
Self-citationLöffler, A., Kufer, P., Lutterbüse, R., Zettl, F., Daniel, P. T., Schwenkenbecher, J. M., Riethmüller, G., Dörken, B., & Bargou, R. C. (2000) · Blood · doi:10.1182/blood.v95.6.2098 · Cited by 445
Self-citationBassan, R., Spinelli, O., Oldani, E., Intermesoli, T., Tosi, M., Peruta, B., Rossi, G., Borlenghi, E., Pogliani, E. M., Terruzzi, E., et al. (2009) · Blood · doi:10.1182/blood-2008-11-185132 · Cited by 430
Mack, M., Riethmüller, G., & Kufer, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.7021 · Cited by 351
Self-citationDreier, T., Lorenczewski, G., Brandl, C., Hoffmann, P., Syring, U., Hanakam, F., Kufer, P., Riethmuller, G., Bargou, R., & Baeuerle, P. A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10557 · Cited by 348
Self-citationHoffmann, P., Hofmeister, R., Brischwein, K., Brandl, C., Crommer, S., Bargou, R., Itin, C., Prang, N., & Baeuerle, P. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.20908 · Cited by 344
Self-citationRaff, T., Gökbuget, N., Lüschen, S., Reutzel, R., Ritgen, M., Irmer, S., Böttcher, S., Horst, H.-A., Kneba, M., Hoelzer, D., et al. (2007) · Blood · doi:10.1182/blood-2006-07-037093 · Cited by 240
Raponi, S., Stefania De Propris, M., Intoppa, S., Laura Milani, M., Vitale, A., Elia, L., Perbellini, O., Pizzolo, G., Foá, R., & Guarini, A. (2011) · Leukemia & Lymphoma · doi:10.3109/10428194.2011.559668 · Cited by 229
Ipilimumab: controversies in its development, utility and autoimmune adverse events
Weber, J. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0653-8 · Cited by 224
Tumor immunosurveillance in human cancers
Mlecnik, B., Bindea, G., Pagès, F., & Galon, J. (2011) · Cancer and Metastasis Reviews · doi:10.1007/s10555-011-9270-7 · Cited by 223
Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
Nagorsen, D., & Baeuerle, P. A. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.03.010 · Cited by 202
Self-citationGranzyme B-induced apoptosis in cancer cells and its regulation (Review)
Krepela (2010) · International Journal of Oncology · doi:10.3892/ijo_00000788 · Cited by 194
BiTE: Teaching antibodies to engage T-cells for cancer therapy.
Baeuerle, P. A., Kufer, P., & Bargou, R. C. (2009) · PubMed · Cited by 192
Self-citationDreier, T., Baeuerle, P. A., Fichtner, I., Grün, M., Schlereth, B., Lorenczewski, G., Kufer, P., Lutterbüse, R., Riethmüller, G., Gjorstrup, P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4397 · Cited by 191
Self-citationBrischwein, K., Parr, L., Pflanz, S., Volkland, J., Lumsden, J., Klinger, M., Locher, M., Hammond, S. A., Kiener, P., Kufer, P., et al. (2007) · Journal of Immunotherapy · doi:10.1097/cji.0b013e318156750c · Cited by 187
Self-citationMode of cytotoxic action of T cell-engaging BiTE antibody MT110
Haas, C., Krinner, E., Brischwein, K., Hoffmann, P., Lutterbüse, R., Schlereth, B., Kufer, P., & Baeuerle, P. A. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.014 · Cited by 178
Self-citationKong, Y., Yoshida, S., Saito, Y., Doi, T., Nagatoshi, Y., Fukata, M., Saito, N., Yang, S. M., Iwamoto, C., Okamura, J., et al. (2008) · Leukemia · doi:10.1038/leu.2008.83 · Cited by 169
Pezzutto, A., Dörken, B., Rabinovitch, P. S., Ledbetter, J. A., Moldenhauer, G., & Clark, E. A. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.9.2793 · Cited by 161
Wahlin, B. E., Sander, B., Christensson, B., & Kimby, E. K. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1734 · Cited by 158
Löffler, A., Gruen, M., Wuchter, C., Schriever, F., Kufer, P., Dreier, T., Hanakam, F., Baeuerle, P. A., Bommert, K., Karawajew, L., et al. (2003) · Leukemia · doi:10.1038/sj.leu.2402890 · Cited by 151
Self-citationHandgretinger, R., Zugmaier, G., Henze, G., Kreyenberg, H., Lang, P., & von Stackelberg, A. (2010) · Leukemia · doi:10.1038/leu.2010.239 · Cited by 143
Brandl, C., Haas, C., d’Argouges, S., Fisch, T., Kufer, P., Brischwein, K., Prang, N. S., Bargou, R. C., Suzich, J., Baeuerle, P. A., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0298-z · Cited by 141
Self-citationBaracho, G. V., Miletic, A. V., Omori, S., Cato, M. H., & RC, R. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.01.001 · Cited by 126
CD19 regulates B lymphocyte responses to transmembrane signals
Fujimoto, M., Poe, J. C., Inaoki, M., & Tedder, T. F. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.9999 · Cited by 109
Mølhøj, M., Crommer, S., Brischwein, K., Rau, D., Sriskandarajah, M., Hoffmann, P., Kufer, P., Hofmeister, R., & Baeuerle, P. A. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.032 · Cited by 103
Self-citationSchlereth, B., Quadt, C., Dreier, T., Kufer, P., Lorenczewski, G., Prang, N., Brandl, C., Lippold, S., Cobb, K., Brasky, K., et al. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0001-1 · Cited by 103
Self-citationImmunotherapy of lymphoma and leukemia with T-cell engaging BiTE antibody blinatumomab
Nagorsen, D., Bargou, R. C., Rüttinger, D., Kufer, P., Baeuerle, P. A., & Zugmaier, G. (2009) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190902943077 · Cited by 102
Self-citationTumor Microenvironment and Immune Escape
Ferrone, S., & Whiteside, T. L. (2007) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2007.08.004 · Cited by 99
d’Argouges, S., Wissing, S., Brandl, C., Prang, N. S., Lutterbuese, R., Kozhich, A., Suzich, J., Locher, M., Kiener, P. A., Kufer, P., et al. (2008) · Leukemia Research · doi:10.1016/j.leukres.2008.08.025 · Cited by 80
Self-citationGruen, M., Bommert, K., & Bargou, R. C. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-003-0496-2 · Cited by 57
Self-citationKischel, P., Guillonneau, F., Dumont, B., Bellahcène, A., Stresing, V., Clézardin, P., Pauw, E. D., & Castronovo, V. (2008) · Neoplasia · doi:10.1593/neo.08570 · Cited by 38
Topp, M. S., Goekbuget, N., Zugmaier, G., Viardot, A., Stelljes, M., Neumann, S., Horst, H. A., Reichle, A., Marks, R., Brüggemann, M., et al. (2011) · Blood · doi:10.1182/blood.v118.21.252.252 · Cited by 32
Self-citationKufer, P., Zettl, F., Borschert, K., Lutterbüse, R., Kischel, R., & Riethmüller, G. (2001) · PubMed · Cited by 31
Self-citationThe potential risk of infections during (prolonged) rituximab therapy in rheumatoid arthritis
Brinkman, I., van de Laar, M. A. F. J., Jansen, T., & van Roon, E. N. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.562188 · Cited by 18
Clinical Experience with Gene Therapy and Bispecific Antibodies for T Cell-based Therapy of Cancer
Baeuerle, P. A., & Itin, C. (2012) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112800785005 · Cited by 9
Self-citationBispecific T Cell Engager for Cancer Therapy
Baeuerle, P. A., Zugmaier, G., & Rüttinger, D. (2011) · Springer eBooks · doi:10.1007/978-3-642-20910-9_15 · Cited by 4
Self-citationKontermann, R. E. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_658 · Cited by 3
Cited by
Acute lymphoblastic leukemia: a comprehensive review and 2017 update
Terwilliger, T., & Abdul-Hay, M. (2017) · Blood Cancer Journal · doi:10.1038/bcj.2017.53 · Cited by 1,288
The making of bispecific antibodies
Brinkmann, U., & Kontermann, R. E. (2017) · mAbs · doi:10.1080/19420862.2016.1268307 · Cited by 923
Engineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Roybal, K. T., Williams, J. Z., Morsut, L., Rupp, L. J., Kolinko, I., Choe, J. H., Walker, W. J., McNally, K. A., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.09.011 · Cited by 721
Topp, M. S., Gökbuget, N., Zugmaier, G., Klappers, P., Stelljes, M., Neumann, S., Viardot, A., Marks, R., Diedrich, H., Faul, C., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.3247 · Cited by 658
Self-citationT cell-engaging therapies — BiTEs and beyond
Goebeler, M.-E., & Bargou, R. C. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0347-5 · Cited by 644
Self-citation
Metadata
- Authors
- Nagorsen, D., Kufer, P., Baeuerle, P. A., & Bargou, R.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 136
- Issue
- 3
- Pages
- 334-342
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2031452426
- Cited by
- 355
- References
- 46
- FWCI
- 21.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.